Nadia Harbeck
纳迪娅·哈贝克
MD
Professor of Gynecology and Obstetrics; Head, Breast Center妇产科学教授；乳腺中心主任
👥Biography 个人简介
Internationally recognized leader in early breast cancer treatment optimization at LMU Munich, directing the ADAPT umbrella trial program that uses early response to guide adaptive neoadjuvant therapy across breast cancer subtypes, advancing response-guided strategies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Adaptive Neoadjuvant Breast Cancer Therapy
Designed and led the ADAPT umbrella trial platform enabling response-guided de-escalation and escalation of neoadjuvant therapy in early breast cancer, establishing early endocrine sensitivity and Ki-67 response as actionable biomarkers.
Representative Works 代表性著作
Neoadjuvant Chemotherapy and HER2 Blockade for HER2-Positive Early Breast Cancer: The WSG ADAPT HER2+/HR- Phase II Trial
Journal of Clinical Oncology (2022)
ADAPT HER2+ trial demonstrating trastuzumab plus pertuzumab without chemotherapy achieves high pCR in selected HER2+/HR- early breast cancer patients.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 纳迪娅·哈贝克 的研究动态
Follow Nadia Harbeck's research updates
留下邮箱，当我们发布与 Nadia Harbeck（LMU University Hospital Munich; Breast Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment